Evidence map›Paper›PMID 26359913›Full record

ArticleThe ISME journal2016

The initial state of the human gut microbiome determines its reshaping by antibiotics.

Frédéric Raymond, Amin A Ouameur, Maxime Déraspe, Naeem Iqbal, Hélène Gingras, Bédis Dridi, Philippe Leprohon, Pier-Luc Plante, Richard Giroux, Ève Bérubé and 12 more

Open access · hybridAbstract read
In one paragraph

Article in The ISME journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 189 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
189citing papers in PubMed, 5 pooled it
11.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

189 citing papers in PubMed, 5 syntheses or guidelines pooled it, 359 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Gut Microbial Diversity in Antibiotic-Naive Children After Systemic Antibiotic Exposure: A Randomized Controlled Trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Trial
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. South African Honey: Anti-International journal of food science · 2026
    Article
  20. Review

129 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 2 institutions in 1 country.

Frédéric RaymondCentre de Recherche en Infectiologie, CHU de Québec-Université Laval, Québec, Canada.
Amin A OuameurCentre de Recherche en Infectiologie, CHU de Québec-Université Laval, Québec, Canada.
Maxime DéraspeCentre de Recherche en Infectiologie, CHU de Québec-Université Laval, Québec, Canada.
Naeem IqbalCentre de Recherche en Infectiologie, CHU de Québec-Université Laval, Québec, Canada.
Hélène GingrasCentre de Recherche en Infectiologie, CHU de Québec-Université Laval, Québec, Canada.
Bédis DridiCentre de Recherche en Infectiologie, CHU de Québec-Université Laval, Québec, Canada.
Philippe LeprohonCentre de Recherche en Infectiologie, CHU de Québec-Université Laval, Québec, Canada.
Pier-Luc PlanteCentre de Recherche en Infectiologie, CHU de Québec-Université Laval, Québec, Canada.
Richard GirouxCentre de Recherche en Infectiologie, CHU de Québec-Université Laval, Québec, Canada.
Ève BérubéCentre de Recherche en Infectiologie, CHU de Québec-Université Laval, Québec, Canada.
Johanne FrenetteCentre de Recherche en Infectiologie, CHU de Québec-Université Laval, Québec, Canada.
Dominique K BoudreauCentre de Recherche en Infectiologie, CHU de Québec-Université Laval, Québec, Canada.
Jean-Luc SimardCentre de Recherche en Infectiologie, CHU de Québec-Université Laval, Québec, Canada.
Isabelle ChabotCentre de Recherche en Infectiologie, CHU de Québec-Université Laval, Québec, Canada.
Marc-Christian DomingoInstitut National de Santé Publique du Québec, Laboratoire de Santé Publique du Québec, Montréal, Québec, Canada.
Sylvie TrottierCentre de Recherche en Infectiologie, CHU de Québec-Université Laval, Québec, Canada.
Maurice BoissinotCentre de Recherche en Infectiologie, CHU de Québec-Université Laval, Québec, Canada.
Ann HuletskyCentre de Recherche en Infectiologie, CHU de Québec-Université Laval, Québec, Canada.
Paul H RoyCentre de Recherche en Infectiologie, CHU de Québec-Université Laval, Québec, Canada.
Marc OuelletteCentre de Recherche en Infectiologie, CHU de Québec-Université Laval, Québec, Canada.
Michel G BergeronCentre de Recherche en Infectiologie, CHU de Québec-Université Laval, Québec, Canada.
Jacques CorbeilCentre de Recherche en Infectiologie, CHU de Québec-Université Laval, Québec, Canada.
Université Laval · CAInstitut National de Santé Publique du Québec · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microbiome studies have demonstrated the high inter-individual diversity of the gut microbiota. However, how the initial composition of the microbiome affects the impact of antibiotics on microbial communities is relatively unexplored. To specifically address this question, we administered a second-generation cephalosporin, cefprozil, to healthy volunteers. Stool samples gathered before antibiotic exposure, at the end of the treatment and 3 months later were analysed using shotgun metagenomic sequencing. On average, 15 billion nucleotides were sequenced for each sample. We show that standard antibiotic treatment can alter the gut microbiome in a specific, reproducible and predictable manner. The most consistent effect of the antibiotic was the increase of Lachnoclostridium bolteae in 16 out of the 18 cefprozil-exposed participants. Strikingly, we identified a subgroup of participants who were enriched in the opportunistic pathogen Enterobacter cloacae after exposure to the antibiotic, an effect linked to lower initial microbiome diversity and to a Bacteroides enterotype. Although the resistance gene content of participants' microbiomes was altered by the antibiotic, the impact of cefprozil remained specific to individual participants. Resistance genes that were not detectable prior to treatment were observed after a 7-day course of antibiotic administration. Specifically, point mutations in beta-lactamase blaCfxA-6 were enriched after antibiotic treatment in several participants. This suggests that monitoring the initial composition of the microbiome before treatment could assist in the prevention of some of the adverse effects associated with antibiotics or other treatments.

Indexed as

AdultAnti-Bacterial AgentsBacteriaBacterial ProteinsCefprozilCephalosporinsFecesFemaleGastrointestinal MicrobiomeHealthy VolunteersHumansMaleMetagenomicsYoung AdultAnti-Bacterial AgentsBacterial ProteinsCefprozilCephalosporins

Identifiers

PMID26359913
PMCPMC4817689
OpenAlexW2180202274

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.